Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profiles.

Saved in:
Bibliographic Details
Title: Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profiles.
Authors: Govindarajan A; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Salgia NJ; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.; Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, United States.; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States., Li H; Integrative Genome Core, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, United States., Castro DV; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Mirzapoiazova T; Integrative Genome Core, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, United States., Armstrong B; Light Microscopy/Digital Imaging Core, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, United States., Zhao D; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Mercier BD; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Dizman N; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States., Chawla N; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Zengin Z; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Meza L; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Tripathi N; Huntsman Cancer Institute-University of Utah Health Care, Salt Lake City, UT, United States., Sayegh N; Huntsman Cancer Institute-University of Utah Health Care, Salt Lake City, UT, United States., Chehrazi-Raffle A; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Tripathi A; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Pal SK; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.
Source: Frontiers in immunology [Front Immunol] 2023 Aug 11; Vol. 14, pp. 1182581. Date of Electronic Publication: 2023 Aug 11 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2023.1182581